A  Hub Angel Investment Group


     Office Locations:

131 Marlborough Street, Unit 4
Boston, MA 02116
Phone: 617-497-2252



  • Early
  • Seed



  • Energy & Clean Tech
  • Life Sciences & Healthcare
  • Media & Digital Media
  • Retail & Restaurant
  • Software & Internet



    Since March 2000, the Hub Angels have reviewed nearly 2,000 early stage technology companies. During that time, the group evolved from an organized club with 15 individuals to one based on limited partners investing through angel funds. Currently there are more than 90 members across the four funds, managing a portfolio of 26 companies. Since 2000, Hub and its members have invested more than $20 million in a broad range of sectors including mobile/media, internet/web services, life sciences, biotechnology, retail and software as a service. Venture firms that have co-invested in Hub's companies include: GE Capital, Flagship, Thomas Weisel, Fidelity, Bessemer, Commonwealth Capital, Intel Capital, Rock Maple, Brook Partners, and Blue Chip. The current Hub Fund IV invests in seed and early stage companies in the New England States, and principally in the Boston area. The Fund has a preference for investing in Series A rounds, but will consider other investment vehicles. The Fund will typically invest $250,000 as a base investment, with co-investment rights of its Members typically providing at least an additional $250,000. A fund reserve of 50% is used for follow-on investments in the group's portfolio companies.

    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Growth Stage
    (also called Mid-stage)
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B

    Investment Team:

    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Charles Cameron Founder and Managing Director
    David Verrill Founder and Managing Director


    Portfolio companies include:

      Catalyst Oncology
        web link

      Dakari Diagnostics
        web link

        web link

        web link

      Exit 41
        web link

      Experion Systems
        web link

        web link

        web link

      Harmony Line
        web link

      Incentive Targeting
        web link

      Intelligent Bio-Systems
        web link

        web link

        web link

        web link

        web link

      National Family Mortgage
        web link

        web link

      Redtail Solutions
        web link

      Seahorse Bioscience
        web link

        web link

        web link


    Recent News: